Drugs for Ovarian Cyst (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 77)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Letrozole |
Approved, Investigational |
Phase 4 |
|
112809-51-5 |
3902 |
Synonyms:
4,4'-(1H-1,2,4-Triazol-1-yl-methylene)-bis(benzonitrile)
CGS-20267
FEM345
Femara
Fémara
|
Femara®
Letrozol
LETROZOLE
Novartis brand OF letrozole
|
|
2 |
|
Etoricoxib |
Approved, Investigational |
Phase 4 |
|
202409-33-4 |
123619 |
Synonyms:
5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulphonyl)phenyl)pyridine
5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-Chloro-3-(4-methanesulphonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-Chloro-6'-methyl-3-(p-(methylsulphonyl)phenyl)-2,3'-bipyridine
Arcoxia
Arcoxia®|MK 0663|MK-0663|MK0663
|
ETORICOXIB
étoricoxib
Etoricoxibum
L791456
L-791456
MK 0663
MK-0663
MK-663
|
|
3 |
|
Danazol |
Approved |
Phase 4 |
|
17230-88-5 |
28417 |
Synonyms:
(17a)-Pregna-2,4-dien-20-yno[2,3-D]isoxazol-17-ol
17 alpha-Pregna-2,4-dien-20-yno[2,3-D] isoxazol-17 beta-ol
17a-Pregna-2,4-dien-20-yne-[2,3-D]isoxazole-17b-ol
17a-Pregna-2,4-dien-20-yno[2,3-D]isoxazol-17-ol
1-Ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-cyclopenta[7,8]phenanthro[3,2-D]isoxazol-1-ol
1H-Cyclopenta[7,8]phenanthro[3,2-D]isoxazole- pregna-2,4-dien-20-yno[2,3-D]isoxazol-17-ol deriv.
Alphapharm brand OF danazol
Antigen brand OF danazol
Azol
Bonzol
Chronogyn
Cyclomen
Danatrol
Danazant
DANAZOL
Danazol ratiopharm
Danazol-ratiopharm
Danazolum
|
Danocrine
Danocrine®
Danol
Danoval
Danovaol
Danzol
Kendrick brand OF danazol
Ladogal
Norciden
NSC-270916
Panacrine
Ratiopharm brand OF danazol
Sanofi brand OF danazol
Sanofi synthelabo brand OF danazol
Sanofi winthrop brand OF danazol
WIN-17757
Winobanin
|
|
4 |
|
Cetrorelix |
Approved, Investigational |
Phase 4 |
|
120287-85-6 |
25074887 |
Synonyms:
Cetrorelix
Cetrorelix acetate
Cetrorelix pamoate
Cetrorelixum
Cetrotide
|
Cetrotide®|SB-075
N-Acetyl-1-(3-(2-naphthyl)alanine)-2-(4-chlorophenylalanine)-3-(3-(3-pyridyl)alanine)-6-citrulline-10-alanine-LHRH
SB 75
SB-075
SB-75
|
|
5 |
|
Ganirelix |
Approved |
Phase 4 |
|
124904-93-4 |
44208957 16186319 16130966 |
Synonyms:
D 24598|D-24598|Orgalutran®|RS 26306|RS-26306
GANIRELIX
GANIRELIX ACETATE
GANIRELIX ACETATE INJECTION
|
ORGALUTRAN
RS-26306
RS-26306-298
|
|
6 |
|
Norethisterone |
Approved |
Phase 4 |
|
68-22-4 |
199472 6230 |
Synonyms:
(-)-Gallocatechin gallic acid
(-)-Gallocatechin-3-O-gallate
(-)-Gallocatechin-3-O-gallic acid
(-)-Gallocatechol gallate
(-)-Gallocatechol gallic acid
(17a)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one
(17Α)-17-ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate)
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoic acid)
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoic acid
17a-Ethinyl-19-nortestosterone
17a-Ethinylestra-4-en-17b-ol-3-one
17a-Ethynyl-17b-hydroxy-19-norandrost-4-en-3-one
17a-Ethynyl-17-hydroxy-4-estren-3-one
17-a-Ethynyl-17-hydroxy-4-estren-3-one
17a-Ethynyl-19-nor-4-androsten-17b-ol-3-one
17a-Ethynyl-19-norandrost-4-en-17b-ol-3-one
17-a-Ethynyl-19-norandrost-4-en-17-b-ol-3-one
17a-Ethynyl-19-nortestosterone
17-a-Ethynyl-19-nortestosterone
17a-Ethynyl-4-estren-17-ol-3-one
17-a-Ethynyl-4-estren-17-ol-3-one
17alpha-Ethinyl-17alpha-ethinyl-19-nortestosterone
17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinylestra-4-en-17beta-ol-3-one
17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one
17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one
17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one
17alpha-Ethynyl-17-hydroxy-4-estren-3-one
17-alpha-Ethynyl-17-hydroxy-4-estren-3-one
17alpha-Ethynyl-17-hydroxyest-4-en-3-one
17alpha-Ethynyl-17-hydroxy-estr-4-en-3-one
17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one
17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one
17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one
17alpha-Ethynyl-19-nortestosterone
17-alpha-Ethynyl-19-nortestosterone
17alpha-Ethynyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-4-estren-17-ol-3-one
17-alpha-Ethynyl-4-estren-17-ol-3-one
17alpha-Pregn-4-en-20-yn-3-one
17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one
17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-Ethinyl-19-nor-testosterone
17-Ethynyl-17beta-hydroxyestr-4-en-3-one
17-Ethynyl-17-hydroxyestr-4-en-3-one (acd/name 4.0)
17-Ethynyl-19-nortestosterone
17-Hydroxy-(17alpha)-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-α-pregn-4-en-20-yn-3-one
17Α-ethinyl-19-nortestosterone
17Α-ethinylestra-4-en-17β-ol-3-one
17Α-ethynyl-17-hydroxy-4-estren-3-one
17-Α-ethynyl-17-hydroxy-4-estren-3-one
17Α-ethynyl-17β-hydroxy-19-norandrost-4-en-3-one
17Α-ethynyl-19-nor-4-androsten-17β-ol-3-one
17Α-ethynyl-19-norandrost-4-en-17β-ol-3-one
17-Α-ethynyl-19-norandrost-4-en-17-β-ol-3-one
17Α-ethynyl-19-nortestosterone
17-Α-ethynyl-19-nortestosterone
17Α-ethynyl-4-estren-17-ol-3-one
17-Α-ethynyl-4-estren-17-ol-3-one
17Î’-hydroxy-19-norpregn-4-en-20-yn-3-one
17-Î’-hydroxy-19-norpregn-4-en-20-yn-3-one
19-Nor-17a-ethynyl-17b-hydroxy-4-androsten-3-one
19-Nor-17-a-ethynyl-17-b-hydroxy-4-androsten-3-one
19-Nor-17a-ethynylandrosten-17b-ol-3-one
19-Nor-17-a-ethynylandrosten-17-b-ol-3-one
19-Nor-17a-ethynyltestosterone
19-Nor-17-a-ethynyltestosterone
19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one
19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one
|
19-Nor-17alpha-ethynyltestosterone
19-Nor-17-alpha-ethynyltestosterone
19-Nor-17-ethinyltestosterone
19-Nor-17α-ethynyl-17β-hydroxy-4-androsten-3-one
19-Nor-17-α-ethynyl-17-β-hydroxy-4-androsten-3-one
19-Nor-17α-ethynylandrosten-17β-ol-3-one
19-Nor-17-α-ethynylandrosten-17-β-ol-3-one
19-Nor-17α-ethynyltestosterone
19-Nor-17-α-ethynyltestosterone
19-Nor-ethindrone
19-Norethinyltestosterone
19-Norethisterone
4-Estren-17a-ethynyl-17b-ol-3-one
4-Estren-17alpha-ethynyl-17beta-ol-3-one
4-Estren-17α-ethynyl-17β-ol-3-one
ACTIVELLA
Anhydrohydroxynorprogesterone
Anovule
AYGESTIN
Camila
COMBIPATCH
Conceplan
Conludaf
Conludag
ENT
ent-Gallocatechin 3-gallic acid
ERRIN
Ethinyl-19-nortestosterone
Ethinylnortestosterone
Ethynylnortestosterone
FEMHRT
Gallocatechin gallate
Gallocatechin-3-gallate
Gestest
HEATHER
INCASSIA
JENCYCLA
Menzol
Micronett
Micronor
MICRONOR HRT
Micronor®|norethindrone|Noriday®
Micronovum
Mini-pe
Mini-pill
Minovlar
Monogest
NEA713
NET
Nor QD
Noralutin
Norcolut
Norcolute
Noresthisterone
NORETHIDRONE
Norethindrone
Norethindrone, (1 beta)-isomer
Norethisteron
Norethisterone
Noréthistérone
Norethisteronum
Norethyndron
Norethynodrone
Noretisterona
Norfor
Norgestin
Noriday
Norlutate
Norluten
Norlutin
Norluton
Normapause
Norpregneninlone
Norpregneninolone
Nor-q.d.
NorQD
Nor-QD
NSC-9564
Primolut N
Primolut-N
Proluteasi
SC-4640
Utovlan
Utovlar
|
|
7 |
|
Progesterone |
Approved, Vet_approved |
Phase 4 |
|
57-83-0 |
5994 |
Synonyms:
(1S,2R,10S,11S,14S,15S)-14-ACETYL-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
(8S,9S,10R,13S,14S,17S)-17-ACETYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9S,10R,13S,14S,17S)-17-ETHANOYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(S)-4-PREGNENE-3,20-DIONE
(S)-PREGN-4-EN-3,20-DIONE
(S)-PROGESTERONE
17ALPHA-PROGESTERONE
17A-PROGESTERONE
17Α-PROGESTERONE
3,20-PREGNENE-4
4-PREGNEN-3,20-DIONE
4-PREGNENE-3,20-DIONE
AGOLUTIN
AKROLUTIN
Amen
BETA-PROGESTERONE
BIO-LUTON
CIDR
COLPROSTERONE
CORLUTIN
CORLUTINA
CORLUVITE
CORPORIN
CORPUS LUTEUM HORMONE
CRINONE
CRINONE PROGESTERONE GEL
CURRETAB
CYCLOGEST
CYCLOGESTERIN
Cycrin
D4-PREGNENE-3,20-DIONE
DELALUTIN
DELTA(4)-PREGNENE-3,20-DIONE
DELTA(SUP 4)-PREGNENE-3,20-DIONE
DURAPROGEN
ENDOMETRIN
ESTIMA
FLAVOLUTAN
FOLOGENON
Gelbkoerperhormon
GELBKÖRPERHORMON
GESTEROL
GESTEROL 100
GESTEROL 50
GESTIRON
GESTONE
GESTORMONE
GESTRON
GLANDUCORPIN
GYNLUTIN
GYNOLUTON
GYNOLUTONE
HORMOFLAVEINE
HORMOLUTON
Hydroxyprogesterone caproate
Hydroxyprogesterone caproic acid
LINGUSORBS
LIPO-LUTIN
LUCORTEUM
LUCORTEUM SOL
LUGESTERON
LUTEAL HORMONE
Luteinique
LUTEOCRIN NORMALE
LUTEODYN
LUTEOGAN
LUTEOHORMONE
LUTEOL
LUTEOPUR
LUTEOSAN
LUTEOSTAB
LUTEOVIS
LUTEUM
LUTEX
LUTIDON
LUTIGEST
|
Lutin
LUTOCICLINA
LUTOCUCLIN M
LUTOCYCLIN
LUTOCYCLIN M
LUTOCYLIN
LUTOCYLOL
LUTOFORM
LUTOGYL
LUTOGYNON
LUTREN
LUTROMONE
MEMBRETTES
METHYLPREGNONE
MPA
NALUTRON
NSC-64377
NSC-9704
PERCUTACRINE
PERCUTACRINE LUTEINIQUE
PIAPONON
PRANONE
PREGN-4-EN-3,20-DIONE
PREGN-4-ENE-3,20-DIONE
PREGNENE-3,20-DIONE
PREGNENEDIONE
PRIMOLUT
PROCHIEVE
PROGEFFIK
PROGEKAN
PROGESTA-CARE
PROGESTAN
PROGESTASERT
PROGESTEROL
PROGESTERON
PROGESTERONA
Progesterona [INN-Spanish]
PROGESTERONE
PROGESTÉRONE
Progesterone, (13 alpha,17 alpha)-(+-)-isomer
Progesterone, (17 alpha)-isomer
Progesterone, (9 beta,10 alpha)-isomer
PROGESTERONUM
Progesteronum [INN-Latin]
PROGESTIN
PROGESTOGEL
PROGESTOL
PROGESTON
PROGESTONE
PROGESTOSOL
PROGESTRON
PROGESTRONOL
PROJESTAJECT
PROLETS
PROLIDON
PROLUTIN
PROLUTON
PROLUTONE
PROMETRIUM
Prometrium®|Utrogestan®
PRONTOGEST
PROTORMONE
REGUMATE
SERENITY FOR WOMEN
SYNGESTERONE
SYNGESTRETS
SYNGESTRONE
SYNOVEX S
SYNTOLUTAN
Thiuram E
Thiuranide
U 3672
UTROGEST
UTROGESTAN
VITARRINE
Δ(4)-pregnene-3,20-dione
|
|
8 |
|
Analgesics |
|
Phase 4 |
|
|
|
9 |
|
Estrogen Receptor Antagonists |
|
Phase 4 |
|
|
|
10 |
|
Estrogen Antagonists |
|
Phase 4 |
|
|
|
11 |
|
Aromatase Inhibitors |
|
Phase 4 |
|
|
|
12 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
13 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
14 |
|
Cyclooxygenase 2 Inhibitors |
|
Phase 4 |
|
|
|
15 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
16 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
17 |
|
Fenugreek seed meal |
|
Phase 4 |
|
|
|
18 |
|
Fenugreek |
|
Phase 4 |
|
|
|
19 |
|
Contraceptives, Oral |
|
Phase 4 |
|
|
|
20 |
|
Contraceptive Agents |
|
Phase 4 |
|
|
|
21 |
|
Contraceptives, Oral, Hormonal |
|
Phase 4 |
|
|
|
22 |
|
Norethindrone Acetate |
|
Phase 4 |
|
|
541197 |
Synonyms:
14-Ethynyl-15-methyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl acetic acid
Aygestin
NORETHIDRONE ACETATE
NORETHINDRONE ACETATE
Norethindrone acetate, (17alpha)-(+-)-isomer
Norethindrone acetate, (17alpha)-isomer
|
Norethindrone acetic acid
Norethisterone acetate
Norlutate
NSC-22844
SH-420
|
|
23 |
|
Ethinylestradiol |
Approved |
Phase 2, Phase 3 |
|
57-63-6 |
5991 |
Synonyms:
(1S,10R,11S,14R,15S)-14-ETHYNYL-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
17 ALPHA-ETHINYLESTRADIOL
17 ALPHA-ETHYNYLESTRADIOL
17 ALPHA-ETHYNYLOESTRADIOL
17α-ethynylestradiol|ethinyl estradiol
17a-Ethinyl estradiol
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol-L7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17Α-ethinyl estradiol
17Α-ETHYNYLESTRADIOL
Alora
Amenoron
Anovlar
Chee-O-gen
Chee-O-genf
Diognat-e
Diogyn e
Diogyn-e
Dyloform
Effik brand OF ethinyl estradiol
ENOVID
ENOVID-E
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Eston-e
Estoral
Estoral {[orion]}
Estorals
Estradiol, ethinyl
Estradiol, ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl estradiol
Ethinyl estradiol hemihydrate
Ethinyl estradiol, (8 alpha)-isomer
Ethinyl estradiol, (8 alpha,17 alpha)-isomer
Ethinyl estradiol, (8 alpha,9 beta,13 alpha,14 beta)-isomer
Ethinyl estradiol, (9 beta,17 alpha)-isomer
Ethinyl oestradiol effik
Ethinylestradiol
Ethinylestradiol jenapharm
ETHINYLESTRADIOLUM
Ethinylestriol
Ethinyloestradiol
|
Ethinyl-oestradiol effik
ETHINYL-OESTRANOL
Ethynyl estradiol
Ethynylestradiol
ETHYNYLOESTRADIOL
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
ETINILESTRADIOL
Etinoestryl
Etistradiol
Etivex
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
Hemihydrate, ethinyl estradiol
Inestra
Innofem
Jenapharm brand OF ethinyl estradiol
Jenapharm, ethinylestradiol
Kolpolyn
Linoral
Lynoral
Menolyn
Menostar
Microfollin
Microfollin forte
Neo-estrone
Nogest-S
NORINYL
Novestrol
NSC-10973
Oradiol
Orestralyn
Orestrayln
Organon brand OF ethinyl estradiol
Ovex
OVULEN
OVULEN-21
OVULEN-28
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn m
Progynon C
Progynon m
Schering brand OF ethinyl estradiol
Schering-plough brand OF ethinyl estradiol
Spanestrin
Thiuram e
Thiuranide
Vagifem
Ylestrol
|
|
24 |
|
Norgestimate |
Approved, Investigational |
Phase 2, Phase 3 |
|
35189-28-7 |
6540478 |
Synonyms:
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(17a)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17Α)-17-(acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime
D-13b-Ethyl-17a-ethynyl-17b-acetoxygon-4-en-3-one oxime
|
D-13Β-ethyl-17α-ethynyl-17β-acetoxygon-4-en-3-one oxime
DEXNORGESTREL
Dexnorgestrel acetime
dexnorgestrel|ORF-10131|RWJ-10131
NORGESTIMATE
Norgestimato
Norgestimatum
Norgestimic acid
Norgestrel oxime acetate
ORF-10131
RWJ-10131
|
|
25 |
|
Ropivacaine |
Approved |
Phase 3 |
|
84057-95-4 |
71273 175805 |
Synonyms:
(-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
(-)-1-Propyl-2',6'-pipecoloxylidide
(+-)-Ropivacaine
(S)-(-)-1-Propyl-2',6'-pipecoloxylidide
(S)-(−)-1-PROPYL-2',6'-PIPECOLOXYLIDIDE
(S)-ROPIVACAINE
1 Propyl 2',6' pipecoloxylidide
1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
1-Propyl-2',6'-pipecoloxylidide
1-propyl-2',6'-pipecoloxylidide|AL-381|LEA-103|Naropin®|ropivacaine hydrochloride
AL-381
DL-Ropivacaine
LEA 103
LEA-103
L-N-N-Propylpipecolate-2,6-xylidide
L-N-N-Propylpipecolic acid-2,6-xylidide
Naropeine
|
Naropin
N-N-Propylpipecolate-2,6-xylidide
N-N-Propylpipecolic acid-2,6-xylidide
Racemic ropivacaine
rac-Ropivacaine
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
Ropivacaine monohydrochloride, (S)-isomer
Ropivacainum
Ropivacainum [INN-Latin]
S-Ropivacaine
|
|
26 |
|
Morphine |
Approved, Investigational |
Phase 3 |
|
57-27-2 |
5288826 |
Synonyms:
(-)-Heroin hydrochloride
(-)-Morphine
(−)-MORPHINE
(5a,6a)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5a,6a)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5Α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5Α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
ANHYDROUS MORPHINE
Apokyn
Astramorph PF
AVINZA
Chloride, morphine
Contin, MS
D-(-)-Morphine
DEPODUR
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dulcontin
Duramorph
Duramorph PF
Duromorph
Epimorph
Heroin hydrochloride
Heroine hydrochloride
IDS-NM-009
INFUMORPH
KADIAN
l-Morphine
M.O.S
Meconium
M-Eslon
Morfina
Morfina dosa
|
Morphia
Morphin
Morphina
MORPHINE
Morphine chloride
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine sulfate
Morphine sulfate (2:1), anhydrous
Morphine sulfate (2:1), pentahydrate
morphine sulfate|Ms Contin®|Oramorph®
Morphinism
Morphinum
Morphitec
Morphium
Moscontin
MS Contin
MS/L
MS/S
MSIR
N02AA01
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
ORAMORPH
Oramorph SR
Ospalivina
Rescudose
RMS Uniserts
Roxanol
Roxanol 100
Roxanol UD
Statex
Statex Drops
Substitol
Sulfate, morphine
|
|
27 |
|
Estradiol |
Approved, Investigational, Vet_approved |
Phase 3 |
|
50-28-2 |
5757 |
Synonyms:
(+)-3,17B-ESTRADIOL
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17BETA)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(17Î’)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(1S,10R,11S,14S,15S)-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
(8R,9S,13S,14S,17S)-13-METHYL-6,7,8,9,11,12,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHRENE-3,17-DIOL
[<sup>3</sup>H]-estradiol|[<sup>3</sup>H]-estrogen|[<sup>3</sup>H]E2|[<sup>3</sup>H]estradiol
13B-METHYL-1,3,5(10)-GONATRIENE-3,17B-OL
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17B-ESTRADIOL
17BETA OESTRADIOL
17BETA-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17BETA-ESTRADIOL
17BETA-OESTRADIOL
17B-OESTRADIOL
17Î’ oestradiol
17Î’-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17β-estradiol
17Î’-OESTRADIOL
3,17B-DIHYDROXYESTRA-1,3,5(10)-TRIENE
3,17B-ESTRADIOL
3,17-EPIDIHYDROXYESTRATRIENE
ADGYN ESTRO
AERODIOL
AGOFOLLIN
ALFATRADIOL
ALORA
ALTRAD
AMNESTROGEN
AQUADIOL
AQUAGEN
BARDIOL
BEDOL
B-ESTRADIOL
BETA-ESTRADIOL
CIS-ESTRADIOL
CLIMADERM
CLIMARA
CLIMARA PRO
COMPUDOSE
CORPAGEN
Delestrogen
DELTA-ESTRADIOL
DELTA-OESTRADIOL
DEPO-ESTRADIOL
DERMESTRIL
DERMESTRIL 100
DERMESTRIL 25
DERMESTRIL 50
DERMESTRIL SEPTEM 25
DERMESTRIL SEPTEM 50
DERMESTRIL SEPTEM 75
DESTRADIOL
D-ESTRADIOL
DIHYDROFOLLICULAR HORMONE
DIHYDROFOLLICULIN
DIHYDROMENFORMON
DIHYDROTHEELIN
DIHYDRO-THEELIN
DIHYDROXYESTRIN
DIMENFORMON
DIOGYN
DIOGYNETS
DIVIGEL
D-OESTRADIOL
E2
E2|estrogen|oestrodiol|oestrogen
E-CYPIONATE
ELESTRIM
ELESTRIN
ELLESTE SOLO
ELLESTE SOLO MX 40
ELLESTE SOLO MX 80
ENCORE
EPIESTRIOL 50
ESCLIM
ESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
ESTRACE
ESTRADERM
ESTRADERM MX 100
ESTRADERM MX 25
ESTRADERM MX 50
ESTRADERM MX 75
ESTRADERM TTS
ESTRADERM TTS 100
ESTRADERM TTS 25
ESTRADERM TTS 50
ESTRADIOL
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
ESTRADIOL HEMIHYDRATE
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol valerate
Estradiol valeriante
|
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17b
ESTRADIOL-17BETA
ESTRADIOL-17-BETA
Estradiol-17β
ESTRADIOLUM
ESTRADOT
ESTRALDINE
ESTRASORB
ESTRING
ESTRING VAGINAL RING
ESTROCLIM
ESTROCLIM 50
ESTROGEL
ESTROGEL HBF
ESTROGEN
ESTROVITE
EVAMIST
EVOREL
EVOREL 100
EVOREL 25
EVOREL 50
EVOREL 75
FEMATRIX 40
FEMATRIX 80
FEMESTRAL
FEMOGEN
FEMPATCH
FEMSEVEN 100
FEMSEVEN 50
FEMSEVEN 75
FOLLICYCLIN
GELESTRA
GINOSEDOL
GVNODIOL
GYNERGON
GYNODIOL
GYNOESTRYL
GYNOGEN
IMVEXXY
INNOFEM
LAMDIOL
MACRODIOL
MENOREST
MENOREST 37.5
MENOREST 50
MENOREST 75
MENORING 50
MENOSTAR
MINIVELLE
NORDICOL
Novartis pharmaceuticals brand OF estradiol
NSC-20293
NSC-9895
OESCLIM
OESTERGON
OESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
OESTRADIOL
OESTRODIOL
OESTROGEL
OESTROGEN
OESTROGLANDOL
Orion brand OF estradiol
OVAHORMON
OVASTEROL
OVASTEVOL
OVOCYCLIN
OVOCYLIN
PERLATANOL
PRIMOFOL
PROFOLIOL
PROFOLIOL B
PROGYNON
Progynon depot
PROGYNON DH
Progynon-depot
Progynova
PROGYNOVA TS
SANDRENA
SANDRENA 1
SYNDIOL
SYSTEN
VAGIFEM
VAGIFEM 18
VAGIFEM 8
VIVELLE
VIVELLE-DOT
WC3011
WC-3011
ZUMENON
Î’-estradiol
|
|
28 |
|
Polyestradiol phosphate |
Approved |
Phase 3 |
|
28014-46-2 |
|
Synonyms:
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol polymer with phosphoric acid
ESTRADIOL PHOSPHATE
Estradiol phosphate polymer
ESTRADURIN
Fosfato de poliestradiol
LEO-114
Oestradiol phosphate polymer
|
Phosphate de polyestradiol
Poly(estradiol phosphate)
POLYEST PHOS
POLYESTRADIOL PHOS PHOSPHATE
POLYESTRADIOL PHOSPHATE
Polyestradioli phosphas
|
|
29 |
|
Anesthetics |
|
Phase 3 |
|
|
|
30 |
|
Anesthetics, Local |
|
Phase 3 |
|
|
|
31 |
|
Estradiol 3-benzoate |
|
Phase 3 |
|
|
|
32 |
|
Estradiol 17 beta-cypionate |
|
Phase 3 |
|
|
|
33 |
|
Contraceptives, Oral, Combined |
|
Phase 3 |
|
|
|
34 |
|
Hormones |
|
Phase 3 |
|
|
|
35 |
|
Estrogens |
|
Phase 3 |
|
|
|
36 |
|
Hormone Antagonists |
|
Phase 3 |
|
|
|
37 |
|
Progestins |
|
Phase 3 |
|
|
|
38 |
|
Racephedrine |
Approved, Experimental |
Phase 1, Phase 2 |
|
299-42-3, 90-82-4, 90-81-3 |
5032 9294 7028 |
Synonyms:
(-)-Ephedrine
(+) Threo-2-(methylamino)-1-phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+-)-Ephedrine
(+)-Pseudoephedrine
(+)-Psi-ephedrine
(+)-Threo-ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-Pseudoephedrine
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
Acunaso
Besan
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-methylamino-1-phenyl-1-propanol
D-Psi-ephedrine
Efedrina
Emerphed® (ephedrine sulfate injection)
Ephedrine
Ephedrine DL-form
Ephedrine erythro isomer
Ephedrine hydrochloride
Ephedrine renaudin
Ephedrine sulfate
Ephedrine threo isomer
Erythro isomer OF ephedrine
Hydrochloride, ephedrine
Isoephedrine
L(-)-Ephedrine
L(−)-EPHEDRINE
|
L-(+)-Pseudoephedrine
L(+)-Psi-ephedrine
L-Ephedrine
L-Erythro-2-(methylamino)-1-phenylpropan-1-ol
Neodurasina
Novafed
NSC-170951
NSC-8971
Pseudoefedrina
Pseudoephedrine
pseudoéphédrine
Pseudoephedrine D-form
Pseudoephedrine ephedrine
Pseudoephedrine HCL
Pseudoephedrine hydrochloride
Pseudoephedrinum
PSEUDOPHEDRINE SULPHATE
Psi-ephedrin
Psi-ephedrine
Racephedrine
Renaudin brand OF ephedrine hydrochloride
Renaudin, ephedrine
Sal phedrine
Sal-phedrine
SalPhedrine
SINUTAB
Sudafed
Sulfate, ephedrine
Threo isomer OF ephedrine
trans-Ephedrine
Wendt brand OF ephedrine sulfate
ψ-ephedrine
|
|
39 |
|
Esmolol |
Approved, Withdrawn |
Phase 1, Phase 2 |
|
103598-03-4, 81147-92-4 |
59768 |
Synonyms:
(±)-ESMOLOL
(±)-METHYL P-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)HYDROCINNAMATE
3-[4-(2-HYDROXY-3-ISOPROPYLAMINO-PROPOXY)-PHENYL]-PROPIONIC ACID METHYL ESTER
ASL-8052-001
Brevibloc
Brevibloc®|SL-8052
|
ESMOLOL
Esmolol hydrochloride
METHYL 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)BENZENEPROPANOATE
METHYL P-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)HYDROCINNAMATE
SL-8052
|
|
40 |
|
Phenylephrine |
Approved |
Phase 1, Phase 2 |
|
59-42-7 |
6041 |
Synonyms:
(-)-m-Hydroxy-a-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol
(−)-m-hydroxy-α-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-α-(methylaminomethyl)benzyl alcohol
(R)-3-[-1-HYDROXY-2-(METHYLAMINO)ETHYL]PHENOL
(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol
AB-101 (PHENYLEPHRINE)
Adrianol
Ak-dilate
Ak-nefrin
Alcon efrin
Alconefrin nasal drops 12
Alconefrin nasal drops 25
Alconefrin nasal drops 50
Alconefrin nasal spray 25
BENZENEMETHANOL, 3-HYDROXY-.ALPHA.-[(METHYLAMINO)METHYL]-, (R)-
BENZENEMETHANOL, 3-HYDROXY-ALPHA-((METHYLAMINO)METHYL)-, (R)-
BENZYL ALCOHOL, M-HYDROXY-ALPHA-((METHYLAMINO)METHYL)-, (-)-
Biomydrin
CYCLOMYDRIL
Dilatair
Dimetane
Dionephrine
Doktors
DUO-MEDIHALER
Duration
Fenilefrina
Fenilefrina [INN-Spanish]
I-phrine
Isophrim
Isophrin
Isopto frin
J8.601K
L-(3-Hydroxyphenyl)-N-methylethanolamine
L-Phenylephedrine
L-Phenylephrine
Mesaton
Mesatone
Mesatonum
Metaoxedrin
Metaoxedrine
Metaoxedrinum
Metasympatol
Metasynephrine
|
Metsatonum
Mezaton
Minims phenylephrine
m-Methylaminoethanolphenol
m-Oxedrine
m-oxedrine|metasynephrine
m-Sympathol
m-Sympatol
m-Synephrine
Mydfrin
Neo synephrine
Neofrin
Neophryn
Neosynephrine
Neo-synephrine
Neo-synephrine nasal drops
Neo-synephrine nasal jelly
Neo-synephrine nasal spray
Neo-synephrine pediatric nasal drops
Nostril
Nostril spray pump
Nostril spray pump mild
Ocugestrin
Ocu-phrin sterile eye drops
Ocu-phrin sterile ophthalmic solution
PEF100
Phenoptic
PHENYLEPHRINE
Phenylephrine hydrochloride
Phenylephrine minims
Phenylephrine tannate
Phenylephrinum
Phenylephrinum [INN-Latin]
Prefrin
Prefrin liquifilm
Pyracort D
R(-)-Mezaton
R(-)-Phenylephrine
Relief eye drops for red eyes
Rhinall
Spersaphrine
Tannate, phenylephrine
Vicks sinex
Visadron
|
|
41 |
|
Oxymetazoline |
Approved, Investigational |
Phase 1, Phase 2 |
|
1491-59-4 |
4636 |
Synonyms:
2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
Afrin
Afrin®|oxymethazoline|SCH-9384|Upneeq® (opthalmic solution)|Vicks Sinex®
Hydrochloride, oxymetazoline
OCUCLEAR
Operil
Oximetazolinum
|
Oxymetazolina
OXYMETAZOLINE
Oxymétazoline
Oxymetazoline hydrochloride
Oxymetazoline hydrochloride crystalline
Oxymetazolinum
Oxymethazoline
Oxymetozoline
SCH-9384
VICKS SINEX
|
|
42 |
|
Neurotransmitter Agents |
|
Phase 1, Phase 2 |
|
|
|
43 |
|
Cardiotonic Agents |
|
Phase 1, Phase 2 |
|
|
|
44 |
|
Adrenergic beta-Antagonists |
|
Phase 1, Phase 2 |
|
|
|
45 |
|
Adrenergic beta-1 Receptor Antagonists |
|
Phase 1, Phase 2 |
|
|
|
46 |
|
Adrenergic Antagonists |
|
Phase 1, Phase 2 |
|
|
|
47 |
|
Adrenergic alpha-Agonists |
|
Phase 1, Phase 2 |
|
|
|
48 |
|
Adrenergic Agonists |
|
Phase 1, Phase 2 |
|
|
|
49 |
|
Adrenergic Agents |
|
Phase 1, Phase 2 |
|
|
|
50 |
|
Vasoconstrictor Agents |
|
Phase 1, Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 55)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation |
Unknown status |
NCT01631253 |
Phase 4 |
|
2 |
The Role of Estrogen in Luteinizing Hormone Surge and Ovulation |
Completed |
NCT01999569 |
Phase 4 |
Letrozole |
3 |
The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Exc |
Completed |
NCT00713778 |
Phase 4 |
|
4 |
Pain Post Abdominal Laparoscopy Prevention With Arcoxia |
Completed |
NCT00565682 |
Phase 4 |
etoricoxib 120 mg |
5 |
Treatment With Danazol Before Controlled Ovarian Hyperstimulation in Women With Endometriosis Undergoing IVF |
Completed |
NCT01779232 |
Phase 4 |
Danazol;placebo |
6 |
Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome |
Completed |
NCT02789488 |
Phase 4 |
|
7 |
A Random Clinical Trial of the Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst |
Completed |
NCT00746278 |
Phase 4 |
|
8 |
GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst - A Proof-of-concept Pilot Study |
Recruiting |
NCT04993924 |
Phase 4 |
Cetrorelix Acetate, Ganerelix Acetate |
9 |
Randomized Control Trial Between Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts |
Not yet recruiting |
NCT05293574 |
Phase 4 |
norethisterone acetate |
10 |
Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women? (Randomized Controlled Study) |
Unknown status |
NCT03357640 |
Phase 2, Phase 3 |
combined oral contraceptive pills |
11 |
Additional Benefit of Hemostatic Sealant in Preserving Ovarian Reserve During Laparoscopic Ovarian Cystectomy: a Randomized Controlled Trial |
Completed |
NCT01857466 |
Phase 3 |
|
12 |
Do Peritoneal Nebulization of Ropivacaine Reduce the Use of Morphine After Short Gynecologic Laparoscopic Surgery? |
Completed |
NCT01142622 |
Phase 3 |
Ropivacaine nebulization;Ropivacaine instillation |
13 |
A Single Center, Randomized, Investigator-initiated Phase III Trial to Evaluate the Efficacy of Preservation of Ovarian Function and Hemostasis, and Its Safety of [email protected] During Laparoscopic Ovarian Cystectomy |
Completed |
NCT03374397 |
Phase 3 |
Surgiguard |
14 |
Single Port Laparoscopy Versus Conventional Laparoscopy for Benign Adnexal Disease - A Randomized Controlled Trial. |
Completed |
NCT01288599 |
Phase 3 |
|
15 |
Treatment of Functional Ovarian Cyst Randomised Clinical Trial |
Not yet recruiting |
NCT05244811 |
Phase 3 |
Combined Oral Contraceptive;Progestin |
16 |
A Prospective, Controlled, Randomized, Multi-Center, Pivotal Study Evaluating the Safety and Efficacy of AdhexilTM in Prevention And/Or Reduction of Adhesions in Gynecology Surgery |
Suspended |
NCT00865488 |
Phase 3 |
|
17 |
The Effects of ß1-receptor Blockade and α1-adrenergic Agonist on the Kinetics of Lactated Ringer's Solution During Surgery |
Completed |
NCT01431612 |
Phase 1, Phase 2 |
Esmolol administration;Phenylephrine infusion;Lactated Ringer´s solution |
18 |
The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cysts: Randomization Clinical Trial |
Unknown status |
NCT03585309 |
|
|
19 |
Monitoring Ovarian Cysts in Pregnancy |
Unknown status |
NCT03440931 |
|
|
20 |
A Multicentre Study to Examine the Short and Long Term Outcomes of the Conservative Management of Benign-looking Adnexal Masses and the Pre-operative Characterisation of Ovarian Tumours |
Unknown status |
NCT01698632 |
|
|
21 |
A New Algorithm to Predict Ovarian Age Combining Clinical, Biochemical and 3D-ultrasonographic Parameters: OvAge |
Unknown status |
NCT02086318 |
|
|
22 |
Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst |
Unknown status |
NCT02482467 |
|
|
23 |
The Efficacy of Progestins in Treatment of Functional Ovarian Cyst |
Unknown status |
NCT03456570 |
Early Phase 1 |
Dydrogesterone 10 mg;Placebo Oral Tablet |
24 |
Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis |
Completed |
NCT03193671 |
|
|
25 |
Comparison Between Abstention and Intrauterine Aspiration in the Treatment of Anechoic Fetal Ovarian Cysts to Prevent Ovarian Torsion |
Completed |
NCT00222066 |
|
|
26 |
The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve : A Prospective Study |
Completed |
NCT02852447 |
|
|
27 |
23 Hour Surgical Model in a Tertiary Hospital: Evaluation From Patient and Organisational Perspective |
Completed |
NCT04142203 |
|
|
28 |
Retrospective Multi-institutional Survey of Clinical Characteristics in Ovarian Clear Cell Adenocarcinoma Cancer Patients |
Completed |
NCT02129036 |
|
|
29 |
The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types |
Completed |
NCT05054946 |
|
|
30 |
Mesial Incision for Laparoscopic Dermoid Cystectomy: a New Safe and Fertility-sparing Technique |
Completed |
NCT01590030 |
|
|
31 |
Laparoscopy-assisted Ovarian Cystectomy: NEW APPROCH |
Completed |
NCT03370952 |
|
|
32 |
Transvaginal Ultrasound Training for the Obstetrics and Gynecology Resident: A Multi-Site Randomized Controlled Trial of Educational DVD |
Completed |
NCT02890914 |
|
|
33 |
Ultrasonographic Evaluation of Ovarian Stroma in PCOS Women |
Completed |
NCT05418595 |
|
|
34 |
Therapeutic Role of Flax Seed for Poly Cystic Ovary Syndrome |
Completed |
NCT03713138 |
|
|
35 |
To Study the Efficacy and Safety of Furocyst in Poly Cystic Ovary Syndrome Patients (PCOS) |
Completed |
NCT02703064 |
|
|
36 |
The Affect of Hemostasis With Bipolar Coagulation Versus SURGIFLO Placement on Ovarian Reserve and Future Fertility |
Completed |
NCT03109964 |
|
|
37 |
Comparison of Optic Nerve Sheath Diameter According to Position During Laparoscopy |
Completed |
NCT01937104 |
|
Desflurane;Remifentanil |
38 |
The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position |
Completed |
NCT01379313 |
|
|
39 |
A Prospective, Multi-Centre, Randomized, Safety and Effectiveness Study of PerClot Compared to Usual Care When Used During Gynaecology Procedures |
Completed |
NCT02835391 |
|
|
40 |
3-dimensional Versus 2-dimensional Laparoscopy Of Ovarian Cyst (LOOC): a Randomized Controlled Trial |
Completed |
NCT03453333 |
|
|
41 |
Diagnosing Ovarian Cysts - the DOC Study |
Recruiting |
NCT04188652 |
|
|
42 |
Ultrasound Elastography in Differentiation of Endometriomas and Hemorrhagic Ovarian Cysts |
Recruiting |
NCT05104086 |
|
|
43 |
Intra-operative Ultrasound Guided Laparoscopic Ovarian Cystectomy (UGLOC) as a Method of Fertility Preservation in the Management of Benign Ovarian Cysts: Randomised Controlled Trial |
Recruiting |
NCT05032846 |
|
|
44 |
Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy |
Recruiting |
NCT04355312 |
|
|
45 |
A Pilot Study to Test Rapid Acquisition of Point of Care Ultrasound for Various Applications |
Recruiting |
NCT02831556 |
|
|
46 |
Ovarian Cyst's Enucleation Spillage Score. An Observational Study of Cyst Characteristics for Spillage During Laparoscopic Enucleation |
Recruiting |
NCT05376384 |
|
|
47 |
Real-Time Identification of Lesions and Nerves by Using Indocyanine Green Fluorescent Imaging in Gynecological Surgery |
Recruiting |
NCT04224467 |
|
|
48 |
A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma |
Recruiting |
NCT04643106 |
|
|
49 |
Pubertal Evolutionary Profile of Children Monitored for Fetal Ovarian Cyst |
Recruiting |
NCT04526392 |
|
|
50 |
Prediction of Malignant Potential of Ovarian Cysts Using Machine Learning Models |
Not yet recruiting |
NCT05342298 |
|
|
|